IP Library Granted Patent US 7,279,332
Granted Patent B2
US 7,279,332 · App. 10/326,438 · Granted Oct 9, 2007

Method of isolating ependymal neural stem cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,279,332
App. No.
10/326,438
Granted
Oct 9, 2007
Kind
B2
Abstract

The present invention relates to a method of determining whether a test compound is a proliferation-inducing or proliferation-inhibiting agent of ependymal neural stem cells. The method comprises: (a) contacting an ependymal neural stem cell with the test compound: and (b) determining the proliferation of the ependymal neural stem cell, wherein if the proliferation of the ependymal neural stem cell is increased in the presence of the test compound as compared to the absence of the test compound, the test compound is identified as a proliferation-inducing agent or wherein if the proliferation of the ependymal neural stem cell is decreased in the presence of the test compound as compared to the absence of the test compound, the test compound is identified as a proliferation-inhibiting agent.

Claims (7)

1. A method of determining whether a test compound is a proliferation-inducing agent, said method comprising:

(a) contacting an ependymal neural stem cell with the test compound; and

(b) determining the proliferation of the ependymal neural stem cell, wherein if the proliferation of the ependymal neural stem cell is increased in the presence of the test compound as compared to the absence of the test compound, the test compound is identified as a proliferation-inducing agent.

2. A method of determining whether a test compound is a proliferation-inhibiting agent, said method comprising:

(a) contacting an ependymal neural stem cell with the test compound; and

(b) determining the proliferation of the ependymal neural stem cell, wherein if the proliferation of the ependymal neural stem cell is decreased in the presence of the test compound as compared to the absence of the test compound, the test compound is identified as a proliferation-inhibiting agent.

3. The method of claim 2 , wherein the method further comprises contacting the ependymal neural stem cell with a proliferation-inducing agent.

Assignments (1)
CHANGE OF NAME Recorded Jul 17, 2014
From: NEURONOVA AB
To: NEWRON SWEDEN AB
Reel/Frame 033358/0554 →